BIOMAT Database Logo BIOMAT Database Logo

[Prevention of thrombosis in surgery: low molecular weight heparin/standard heparin]. 1990

H A Weinand, and T Gehrke, and H Krieg, and H Brünner
Institut für Hygiene, Städtische Krankenanstalten Krefeld.

In a randomized study the efficiency of the low molecular weight heparin (LMWH) Fragmin and unfractionated heparin Calciparin in preventing thromboembolic disease was examined. Ninety patients undergoing a herniotomy participated in the study. The LMWH also showed good efficiency in a laboratory test of anti-factor Xa-activity. There were no complications.

UI MeSH Term Description Entries
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006495 Heparin, Low-Molecular-Weight Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. LMWH,Low-Molecular-Weight Heparin,Low Molecular Weight Heparin,Heparin, Low Molecular Weight
D006552 Hernia, Inguinal An abdominal hernia with an external bulge in the GROIN region. It can be classified by the location of herniation. Indirect inguinal hernias occur through the internal inguinal ring. Direct inguinal hernias occur through defects in the ABDOMINAL WALL (transversalis fascia) in Hesselbach's triangle. The former type is commonly seen in children and young adults; the latter in adults. Inguinal Hernia,Inguinal Hernia, Direct,Inguinal Hernia, Indirect,Direct Inguinal Hernia,Direct Inguinal Hernias,Hernia, Direct Inguinal,Hernia, Indirect Inguinal,Hernias, Direct Inguinal,Hernias, Indirect Inguinal,Hernias, Inguinal,Indirect Inguinal Hernia,Indirect Inguinal Hernias,Inguinal Hernias,Inguinal Hernias, Direct,Inguinal Hernias, Indirect
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms

Related Publications

H A Weinand, and T Gehrke, and H Krieg, and H Brünner
[Potentials risks in drug prevention of thrombosis--low-molecular-weight heparin versus standard heparin].
January 1999, Zeitschrift fur Orthopadie und ihre Grenzgebiete,
H A Weinand, and T Gehrke, and H Krieg, and H Brünner
[Thrombosis prevention with low molecular weight heparin].
July 1987, Medizinische Monatsschrift fur Pharmazeuten,
H A Weinand, and T Gehrke, and H Krieg, and H Brünner
Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery.
June 1992, Thrombosis and haemostasis,
H A Weinand, and T Gehrke, and H Krieg, and H Brünner
Low molecular weight heparin in prevention of perioperative thrombosis.
October 1992, BMJ (Clinical research ed.),
H A Weinand, and T Gehrke, and H Krieg, and H Brünner
[Prevention of thrombosis with low molecular weight heparin in gynecology].
January 1995, Zentralblatt fur Gynakologie,
H A Weinand, and T Gehrke, and H Krieg, and H Brünner
Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
April 1991, Annals of internal medicine,
H A Weinand, and T Gehrke, and H Krieg, and H Brünner
Low molecular weight heparin prevention of post-operative deep vein thrombosis in vascular surgery.
January 1988, Pharmatherapeutica,
H A Weinand, and T Gehrke, and H Krieg, and H Brünner
[Prevention of thrombosis with low molecular weight heparin and hydroxyethyl starch in general surgery].
January 1990, Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress,
H A Weinand, and T Gehrke, and H Krieg, and H Brünner
Low-molecular-weight heparin for prevention of thrombosis: inverted role.
November 2007, The Journal of trauma,
H A Weinand, and T Gehrke, and H Krieg, and H Brünner
[Prevention of thrombosis with unfractionated and low molecular weight heparin].
December 1989, Wiener medizinische Wochenschrift (1946),
Copied contents to your clipboard!